{"id":16989,"date":"2023-05-08T12:19:00","date_gmt":"2023-05-08T11:19:00","guid":{"rendered":"https:\/\/vascular.hu\/holding\/?p=16989"},"modified":"2024-02-09T12:20:19","modified_gmt":"2024-02-09T11:20:19","slug":"project-news","status":"publish","type":"post","link":"https:\/\/vascular.hu\/holding\/project-news\/","title":{"rendered":"Project news"},"content":{"rendered":"<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"688\" height=\"279\" src=\"https:\/\/vascular.hu\/holding\/wp-content\/uploads\/2024\/02\/n1.png\" alt=\"\" class=\"wp-image-16990\" srcset=\"https:\/\/vascular.hu\/holding\/wp-content\/uploads\/2024\/02\/n1.png 688w, https:\/\/vascular.hu\/holding\/wp-content\/uploads\/2024\/02\/n1-300x122.png 300w\" sizes=\"(max-width: 688px) 100vw, 688px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">Our chlorotoxin-analog (CTXA) targeted CAR T asset is not only strong by scientific means but also holds strong IP protection. The project reached an important milestone: we received the International Preliminary Report on Patentability for our patent application (PCT\/HU2021\/050075). The result is: all claims have been accepted in terms of all requirements of patentability!<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">We\u2019ll continue our progress and keep you updated.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Our chlorotoxin-analog (CTXA) targeted CAR T asset is not only strong by scientific means but also holds strong IP protection. The project reached an important milestone: we received the International Preliminary Report on Patentability for our patent application (PCT\/HU2021\/050075). The result is: all claims have been accepted in terms of all requirements of patentability! We\u2019ll [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[81,42],"tags":[],"class_list":["post-16989","post","type-post","status-publish","format-standard","hentry","category-news","category-vascular-reserach-group"],"_links":{"self":[{"href":"https:\/\/vascular.hu\/holding\/wp-json\/wp\/v2\/posts\/16989","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vascular.hu\/holding\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vascular.hu\/holding\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vascular.hu\/holding\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/vascular.hu\/holding\/wp-json\/wp\/v2\/comments?post=16989"}],"version-history":[{"count":1,"href":"https:\/\/vascular.hu\/holding\/wp-json\/wp\/v2\/posts\/16989\/revisions"}],"predecessor-version":[{"id":16991,"href":"https:\/\/vascular.hu\/holding\/wp-json\/wp\/v2\/posts\/16989\/revisions\/16991"}],"wp:attachment":[{"href":"https:\/\/vascular.hu\/holding\/wp-json\/wp\/v2\/media?parent=16989"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vascular.hu\/holding\/wp-json\/wp\/v2\/categories?post=16989"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vascular.hu\/holding\/wp-json\/wp\/v2\/tags?post=16989"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}